Establishing and explaining a baseline of octamethylcyclotetrasiloxane (D4) and decamethylcyclopentasiloxane (D5) in end-exhaled air and urine.

Establishing and explaining a baseline of octamethylcyclotetrasiloxane (D4) and decamethylcyclopentasiloxane (D5) in end-exhaled air and urine. - Establising an explaining a baseline of D4/D5.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON36073

Enrollment

Registered

2012-06-20

Start date

2013-02-25

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

synergistische blootstelling aggregated exposure

Interventions

The volunteers will be exposed to: - 2 g pure substance D4 - 2 g pure substance D5 - a crème containing D4 or D5 - a deodorant containing D4 or D5 - a crème + deodorant containing D4 or D5

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: good general health above 18 years of age

Exclusion criteria

Exclusion criteria: pregnancy women who are not taking birth control measures skin diseases (in which hyperkeratoses occurs) specific occupations: dry cleaner, make-up artist, hairdresser

Design outcomes

Primary

Measure	Time frame
The concentration D4/D5 in end-exhaled air.	—

Secondary

Measure	Time frame
The concentration of D4/D5 in urine.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)